Testing Lung Cancer Patients’ and Oncologists’ Experience with the Lalaby App for Monitoring the Quality of Life through Mobile Sensors and Integrated Questionnaires

Figures & data

Figure 1. Lalaby app screenshot of the main menu (left), activities (centre), symptoms (right).

Figure 2. Lalaby app screenshot of the questionnaire menu (left), first question of the EORTC-C30 questionnaire (centre), first question of the ECOG-PS questionnaire (right).

Figure 3. (Top) graph from the Lalaby dashboard of the daily sensor records for Patient 1, (bottom) reported activities, symptoms, and events (chemotherapy cycles).

Table 1. Summary table of mean values of the data obtained by the patients’ sensors per day.

Measurement	Patient 1	Patient 2
Total number of calls	81	27
Total data usage (MB)	13797.2 MB	2873 MB
Total distance travelled (km)	2.14 km	3.19 Km
Mean quantity of movement (m/s^2)	0.22 m/s^2	0.04 m/s^2
Mean frequencies of sound (HZ)	379.7 Hz	807.7 Hz

Table 2. Summary table of activities, symptoms report EORTC QLQ-C30, ECOG and UEQ-S by Patient 1 and 2

Measurement	Patient 1	Patient 2
Times activities/symptoms reported	47	30
Days with report	31	29
Number of activities	168	83
Number of symptoms	63	89
Most frequent activities (in order)	Resting, personal cleanliness, watching TV, walking, and a little time occupied with social life	Walking and watching TV, personal cleanliness, going shopping, housework, social life, resting, using a computer, and going by transport
Most frequent symptoms (in order)	Tiredness, pain, dizziness, and lack of air	Tiredness, pain, vomiting, dizziness, shortness of breath
Times EORTC QLQ-C30 reported	51	14
Times ECOG reported	17	8
Times UEQ-S reported	24	4

Figure 4. Patient 1: grap of the UEQ-S scales from the Lalaby dashboard. E (Event) indicates dates with “oncologic treatment.” [−0.8, 0.8] Neutral evaluation; [0.8, 3.0] Positive evaluation; [−3.0, −0.8] Negative evaluation.

Figure 5. Patient 2: graph of the UEQ-s scales from the Lalaby dashboard. E (Event) indicates dates with “oncologic treatment.” [−0.8, 0.8] Neutral evaluation; [0.8, 3.0] Positive evaluation; [−3.0, −0.8] Negative evaluation.

Figure 6. Normalized mean values (0–100 scale) of the usability measures obtained in the onchologists Task test.